Direkt zum Inhalt
Merck

Fortfahren mit

33-055

PIP4-Kinase HTRF Assay

The PIP4 Kinase HTRF Assay kit provides a method for assaying PI(5)P-4 kinases in a homogenous 1920 well format. Suitable for screening of potential inhibitors of these enzymes.

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Über diesen Artikel

eCl@ss:
32161000
UNSPSC Code:
12161503


species reactivity

human, mouse

manufacturer/tradename

HTRF®, Upstate®

technique(s)

activity assay: suitable (kinase)

NCBI accession no.

detection method

fluorometric (HTRF)

shipped in

dry ice

Application

Research Category
Apoptosis & Cancer
Research Sub Category
Oncology
The PIP4 Kinase HTRF Assay kit provides a method for assaying PI(5)P-4 kinases in a homogenous 1920 well format. Suitable for screening of potential inhibitors of these enzymes.
Used to detect/quantify: PIP4 Kinase

Biochem/physiol Actions

Target Sub-Family: PI3K/PI4K

Packaging

Kit capacity: 1920 wells

Preparation Note

12 months at -70°C

Other Notes

Reaction Buffer (4X)

DM A Detection Reagent

DM C Detection Reagent

DM E Detection Reagent

Phosphatidylinositol 5-phosphate (1mM)

Phosphatidylserine (1mM)

Stop Reagent D

Legal Information

HTRF is a registered trademark of Cis Bio International
UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Lagerklasse

10-13 - German Storage Class 10 to 13



Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Lars Wortmann et al.
Journal of medicinal chemistry, 64(21), 15883-15911 (2021-10-27)
PIP4K2A is an insufficiently studied type II lipid kinase that catalyzes the conversion of phosphatidylinositol-5-phosphate (PI5P) into phosphatidylinositol 4,5-bisphosphate (PI4,5P2). The involvement of PIP4K2A/B in cancer has been suggested, particularly in the context of p53 mutant/null tumors. PIP4K2A/B depletion has



Questions

Reviews

No rating value

Active Filters